Oruka Therapeutics, Inc. (ABIO)
Delisted
30 Aug 2024
NASDAQ (CM) NASDAQ (CM) Primary $
28. 80
+26.3
+1,052%
$
34.82M Market Cap
- P/E Ratio
6.36% Div Yield
24,237 Volume
0 Eps
$ 2.5
Previous Close Day Range
26.64 29.64
Year Range
1.56 29.64
Want to track ABIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
